Advertisement

Topics

UPDATE 1-Drug developer GW Pharma to cancel London listing

23:50 EDT 18 Oct 2016 | Reuters

Oct 19 (Reuters) - Britain's GW Pharmaceuticals Plc , a developer of marijuana-based epilepsy treatments, said it planned to cancel its listing in London's junior market and would retain listing of its American Depositary Receipts (ADRs) on Nasdaq t...

Original Article: UPDATE 1-Drug developer GW Pharma to cancel London listing

NEXT ARTICLE

More From BioPortfolio on "UPDATE 1-Drug developer GW Pharma to cancel London listing"

Quick Search
Advertisement
 

Relevant Topic

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...